RESTASIS - 0023-9163-60 - (cyclosporine)

Alphabetical Index


Drug Information of RESTASIS

Product NDC: 0023-9163
Proprietary Name: RESTASIS
Non Proprietary Name: cyclosporine
Active Ingredient(s): .5    mg/mL & nbsp;   cyclosporine
Administration Route(s): OPHTHALMIC
Dosage Form(s): EMULSION
Coding System: National Drug Codes(NDC)

Labeler Information of RESTASIS

Product NDC: 0023-9163
Labeler Name: Allergan, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA050790
Marketing Category: NDA
Start Marketing Date: 20030401

Package Information of RESTASIS

Package NDC: 0023-9163-60
Package Description: 60 VIAL, SINGLE-USE in 1 TRAY (0023-9163-60) > .4 mL in 1 VIAL, SINGLE-USE

NDC Information of RESTASIS

NDC Code 0023-9163-60
Proprietary Name RESTASIS
Package Description 60 VIAL, SINGLE-USE in 1 TRAY (0023-9163-60) > .4 mL in 1 VIAL, SINGLE-USE
Product NDC 0023-9163
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name cyclosporine
Dosage Form Name EMULSION
Route Name OPHTHALMIC
Start Marketing Date 20030401
Marketing Category Name NDA
Labeler Name Allergan, Inc.
Substance Name CYCLOSPORINE
Strength Number .5
Strength Unit mg/mL
Pharmaceutical Classes Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]

Complete Information of RESTASIS


General Information